Dr Sue Clenton, Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of...
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
The party has passed a motion that aims to protect patients from discrimination related to their use of prescribed cannabis medicines.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business...
People who consumed THC were more likely to recall words that were never shown to them.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
A small pilot study suggests Epidiolex may have benefits for weight restoration and symptom improvement in anorexia patients.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
New research suggests that long-term, heavy cannabis use is associated with subtle changes to the brain's frontal cortex.
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and...
